Clinical trial NCT06961981: Remote Vinyasa Yoga Program for Heart Health
Official title: Feasibility, Acceptability, and Preliminary Efficacy of a Remote Vinyasa Yoga Program for Heart Health
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Hypertension
Cardiovascular Diseases
Keywords: Yoga
vinyasa yoga
Lead sponsor: West Virginia University
Sponsor class: OTHER
First posted: 2025-05-08
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to test a 12-week vinyasa yoga (flow yoga) intervention via Zoom. This program will be for 30 individuals with high blood pressure. 15 will receive the intervention and 15 will follow their usual routine. The investigators will determine if this vinyasa yoga program is feasible and acceptable in this population. Investigators will measure and compare blood pressure and other health responses such as physical health and well-being before and after participants complete the intervention or usual care period. The investigators hope to demonstrate that vinyasa yoga is a good option to improve heart health in people with high blood pressure.

Primary Objective - Examine the feasibility, acceptability, and preliminary efficacy of a 12-wk remotely-delivered vinyasa yoga intervention (3 x per week) on cardiovascular (CV) health in adults with hypertension (HTN).


Eligibility criteria: Inclusion Criteria:

* Individuals with a resting systolic BP \>130 mmHg

Exclusion Criteria:

* Report currently meeting aerobic activity guidelines (150 min/wk)
* Practice yoga regularly (1 or more day/wk in the past month)
* Have physical limitations or a major medical condition contraindicating yoga or assessments
* Have uncontrolled HTN (systolic BP 160 mmHg or diastolic BP 100 mmHg)
* Are currently pregnant or planning to become pregnant within 6 months
* Are not on a stable dose of medications that could affect study outcomes
* Are concurrently enrolled in another lifestyle program
* No vulnerable populations will be included

Primary outcomes:
measure: Change in Carotid-Femoral Pulse Wave Velocity
timeFrame: Baseline to 12 weeks
Secondary outcomes:
measure: Change in systolic blood pressure
timeFrame: Baseline to 12 weeks
measure: Change in diastolic blood pressure
timeFrame: Baseline to 12 weeks
measure: Change in augmentation pressure
timeFrame: Baseline to 12 weeks
measure: Change in augmentation index
timeFrame: Baseline to 12 weeks
measure: Change in mean heart rate
timeFrame: Baseline to 12 weeks
measure: Change in standard deviation of normal R-R Intervals
timeFrame: Baseline to 12 weeks
measure: Change in root mean square of successive differences
timeFrame: Baseline to 12 weeks
measure: Change in high frequency heart rate variability
timeFrame: Baseline to 12 weeks
measure: Change in low frequency heart rate variability
timeFrame: Baseline to 12 weeks
measure: Change in low frequency to high frequency ratio
timeFrame: Baseline to 12 weeks
measure: Change in body mass index
timeFrame: Baseline to 12 weeks
measure: Change in waist-to-hip-ratio
timeFrame: Baseline to 12 weeks
measure: Change in total body fat percentage
timeFrame: Baseline to 12 weeks
measure: Change in fat mass
timeFrame: Baseline to 12 weeks
measure: Change in fat free mass
timeFrame: Baseline to 12 weeks
measure: Change in skeletal muscle mass
timeFrame: Baseline to 12 weeks
measure: Change in estimated maximal oxygen consumption (VO2)
timeFrame: Baseline to 12 weeks
measure: Change in 1-repetition maximum testing - Seated chest press
timeFrame: Baseline to 12 weeks
measure: Change in 1-repetition maximum testing - Seated leg press
timeFrame: Baseline to 12 weeks
measure: Change in time-based muscular endurance tests - wall sit
timeFrame: Baseline to 12 weeks
measure: Change in Time-based muscular endurance test - plank
timeFrame: Baseline to 12 weeks
measure: Change in count-based muscular endurance test - push-up test
timeFrame: Baseline to 12 weeks
measure: Change in upper body flexibility
timeFrame: Baseline to 12 weeks
measure: Change in lower body flexibility
timeFrame: Baseline to 12 weeks
measure: Change in perceived stress
timeFrame: Baseline to 12 weeks
measure: Change in perceived depressive symptoms
timeFrame: Baseline to 12 weeks
measure: Change in perceived sleep
timeFrame: Baseline to 12 weeks
measure: Change in body image perception
timeFrame: Baseline to 12 weeks
measure: Change in perceived anxiety symptoms
timeFrame: Baseline to 12 weeks
Other outcomes:
Locations:
city: Morgantown
country: United States
facility: West Virginia University
state: West Virginia
Study officials:
affiliation: West Virginia University
name: Bethany Barone Gibbs, PhD
role: PRINCIPAL_INVESTIGATOR
References: